Truvelog 100 U Solution for injection
PDF Leaflet Revision Date: 04 April 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of diabetes mellitus in patients aged 1 year and above.
Dosage (summary)
0.5 to 1 units/kg/day, adjusted based on individual needs.
Onset of Action / Duration
Onset: 10-20 mins, Duration: 3-5 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Paediatric population
Pregnancy & Breastfeeding
Safe in pregnancy and breastfeeding; insulin requirements may change.
Key Drug Interactions
- Oral antidiabetic medicines
- Beta-blockers
- Glucocorticoids
- Alcohol
Contraindications
- Hypersensitivity to insulin aspart or excipients
Common side effects
- Hypoglycaemia
- Injection site reactions
- Lipodystrophy
Counselling Points
- Monitor blood glucose regularly
- Administer immediately before meals
- Rotate injection sites to reduce lipodystrophy risk
Serious warnings
- Risk of hyperglycaemia and diabetic ketoacidosis with inadequate dosing
- Hypoglycaemia may occur if insulin dose is too high
Important Disclaimer
The Truvelog 100 U Solution for injection professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
